Generic name · Colony Stimulating Factor
Pegfilgrastim J-Code / HCPCS Code
In short
Pegfilgrastim is billed under HCPCS J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg. One billing unit is 0.5 mg.
Pegfilgrastim biosimilars have their own HCPCS codes.
Reference
- Code
- J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mgMed-Code curated
- Billing unit
- 0.5 mg
- Same code in the directory
- Neulasta
- Pharmacologic class
- Leukocyte Growth FactorFrom the FDA listings below
- Labelers
- Accord BioPharma, Inc.; Amgen, Inc; Amneal Pharmaceuticals LLC; Biocon Biologics Inc.; Coherus Oncology, Inc.; Lupin Pharmaceuticals, Inc.; Pfizer Laboratories Div Pfizer Inc; Sandoz Inc
- J-code category
- Colony Stimulating Factor
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Armlupegpegfilgrastim-unne | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Lupin Pharmaceuticals, Inc. | 70748-273 |
| Fulphilapegfilgrastim-jmdb | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Biocon Biologics Inc. | 83257-005 |
| Fylnetrapegfilgrastim | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | 70121-1627 |
| Neulastapegfilgrastim | Pegfilgrastim 4 mg/.4mL | SolutionSubcutaneous | Amgen, Inc | 55513-099 |
| Neulastapegfilgrastim | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Amgen, Inc | 55513-190 |
| Nyvepriapegfilgrastim-apgf | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Pfizer Laboratories Div Pfizer Inc | 0069-0324 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Accord BioPharma, Inc. | 69448-025 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Accord BioPharma, Inc. | 69448-026 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Accord BioPharma, Inc. | 69448-027 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Coherus Oncology, Inc. | 70114-101 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Coherus Oncology, Inc. | 70114-120 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | Coherus Oncology, Inc. | 70114-130 |
| Ziextenzopegfilgrastim-bmez | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Sandoz Inc | 61314-866 |
Other products with this name
Same name but a different route, formulation or combination — the code above does not apply to these.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Neulastapegfilgrastim | — | Kit | Amgen, Inc | 55513-192 |
NDCs billed under J2506
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 3 NDCs to J2506 for Neulasta. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Neulasta | 55513-0099-01 | Amgen Inc | 0.4 | 8 |
| Neulasta | 55513-0190-01 | Amgen Inc | 0.6 | 12 |
| Neulasta | 55513-0192-01 | Amgen Inc | 0.6 | 12 |